_id
6913113dccc777a4e85d7ebe
Ticker
LTRN
Name
Lantern Pharma Inc
Exchange
NASDAQ
Address
1920 McKinney Avenue, Dallas, TX, United States, 75201
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.lanternpharma.com
Description
Lantern Pharma Inc. focuses on the discovery and development of oncology drug. Its product pipeline comprises LP-300, which is in phase 2 clinical trial in combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma; LP-184, which is in phase 1 clinical trial for the treatment of solid tumor, such as pancreatic, breast, bladder, and lung cancers, as well as glioblastoma and other central nervous system (CNS) cancers; and LP-284, which is in phase 1 clinical trial for the treatment of non-Hodgkin's lymphomas, including mantle cell lymphoma and double hit lymphoma. The company also develops STAR-001, which is in preclinical development for the treatment of glioblastoma, brain metastases, atypical teratoid rhabdoid tumors, and several rare pediatric CNS cancers. In addition, it provides ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. The company has a strategic AI-driven collaboration with Oregon Therapeutics to optimize the development of its first-in-class protein disulfide isomerase inhibitor drug candidate XCE853 in novel and targeted cancer indications; a collaboration agreement with TTC Oncology, which focuses on the drug development of TTC-352 to treat patients with metastatic ER+ breast cancer; and a collaboration agreement with Actuate Therapeutics, Inc. that focuses on the development of compounds for use in the treatment of cancer and inflammatory diseases. The company was incorporated in 2013 and is headquartered in Dallas, Texas.
Last Close
3.37
Volume
21741
Current Price
3.31
Change
-1.7804154302670638
Last Updated
2025-12-02T11:25:48.937Z
Image
data:image/webp;base64,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
Ipo Date
2020-06-11T00:00:00.000Z
Market Cap
39257324
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
5
Target Price
22
Strong Buy
2
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
4102
Gross Profit
-4102
Operating Expenses
4345698
Operating Income
-4349800
Interest Expense
-
Pretax Income
-4177423
Net Income
-4177423
Eps
-0.3856061531230336
Dividends Per Share
-
Shares Outstanding
11184423
Income Tax Expense
-
EBITDA
-4173321
Operating Margin
-
Total Other Income Expense Net
172377
Cash
8389486
Short Term Investments
3973090
Receivables
-
Inventories
-
Total Current Assets
13461005
Property Plant Equipment
129066
Total Assets
13626810
Payables
3946018
Short Term Debt
93954
Long Term Debt
-
Total Liabilities
4039971
Equity
9586838
Depreciation
4102
Change In Working Capital
-656783
Cash From Operations
-4571980
Capital Expenditures
560
Cash From Investing
5928538
Cash From Financing
971781
Net Change In Cash
2328078
PE
-
PB
3.7403918612163887
ROE
-43.57456546152131
ROA
-30.655912865887174
FCF
-4572540
Fcf Percent
-
Piotroski FScore
0
Health Score
37
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
4102
Quarters > 0 > income Statement > gross Profit
-4102
Quarters > 0 > income Statement > operating Expenses
4345698
Quarters > 0 > income Statement > operating Income
-4349800
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-4177423
Quarters > 0 > income Statement > net Income
-4177423
Quarters > 0 > income Statement > eps
-0.3856061531230336
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
10833393
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-4173321
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
172377
Quarters > 0 > balance Sheet > cash
8389486
Quarters > 0 > balance Sheet > short Term Investments
3973090
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
13461005
Quarters > 0 > balance Sheet > property Plant Equipment
129066
Quarters > 0 > balance Sheet > total Assets
13626810
Quarters > 0 > balance Sheet > payables
3946018
Quarters > 0 > balance Sheet > short Term Debt
93954
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4039971
Quarters > 0 > balance Sheet > equity
9586838
Quarters > 0 > cash Flow > net Income
-4177423
Quarters > 0 > cash Flow > depreciation
4102
Quarters > 0 > cash Flow > change In Working Capital
-656783
Quarters > 0 > cash Flow > cash From Operations
-4571980
Quarters > 0 > cash Flow > capital Expenditures
560
Quarters > 0 > cash Flow > cash From Investing
5928538
Quarters > 0 > cash Flow > cash From Financing
971781
Quarters > 0 > cash Flow > net Change In Cash
2328078
Quarters > 0 > ratios > PE
-0.3856061531230336
Quarters > 0 > ratios > PB
3.7403918612163887
Quarters > 0 > ratios > ROE
-43.57456546152131
Quarters > 0 > ratios > ROA
-30.655912865887174
Quarters > 0 > ratios > FCF
-4572540
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
37
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
4501
Quarters > 1 > income Statement > gross Profit
-4501
Quarters > 1 > income Statement > operating Expenses
4651900
Quarters > 1 > income Statement > operating Income
-4651900
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-4331015
Quarters > 1 > income Statement > net Income
-4331015
Quarters > 1 > income Statement > eps
-0.40158789398895195
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
10784725
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4647399
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
320885
Quarters > 1 > balance Sheet > cash
6061408
Quarters > 1 > balance Sheet > short Term Investments
9840366
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
17200790
Quarters > 1 > balance Sheet > property Plant Equipment
182764
Quarters > 1 > balance Sheet > total Assets
17420292
Quarters > 1 > balance Sheet > payables
4752848
Quarters > 1 > balance Sheet > short Term Debt
131515
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
4897887
Quarters > 1 > balance Sheet > equity
12522405
Quarters > 1 > cash Flow > net Income
-4331015
Quarters > 1 > cash Flow > depreciation
4501
Quarters > 1 > cash Flow > change In Working Capital
381885
Quarters > 1 > cash Flow > cash From Operations
-3937277
Quarters > 1 > cash Flow > capital Expenditures
3
Quarters > 1 > cash Flow > cash From Investing
3593158
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-316194
Quarters > 1 > ratios > PE
-0.40158789398895195
Quarters > 1 > ratios > PB
2.850685611110645
Quarters > 1 > ratios > ROE
-34.58612782448739
Quarters > 1 > ratios > ROA
-24.86189668921738
Quarters > 1 > ratios > FCF
-3937280
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
100654
Quarters > 2 > income Statement > cost Of Revenue
4574
Quarters > 2 > income Statement > gross Profit
-4574
Quarters > 2 > income Statement > operating Expenses
4774032
Quarters > 2 > income Statement > operating Income
-4774032
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-4536783
Quarters > 2 > income Statement > net Income
-4536783
Quarters > 2 > income Statement > eps
-0.4206674718177793
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
10784725
Quarters > 2 > income Statement > income Tax Expense
-3
Quarters > 2 > income Statement > EBITDA
-4769458
Quarters > 2 > income Statement > operating Margin
-4743.012696961869
Quarters > 2 > income Statement > total Other Income Expense Net
237249
Quarters > 2 > balance Sheet > cash
6377602
Quarters > 2 > balance Sheet > short Term Investments
13344049
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
20823376
Quarters > 2 > balance Sheet > property Plant Equipment
236221
Quarters > 2 > balance Sheet > total Assets
21096335
Quarters > 2 > balance Sheet > payables
4124919
Quarters > 2 > balance Sheet > short Term Debt
161515
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
4319850
Quarters > 2 > balance Sheet > equity
16776485
Quarters > 2 > cash Flow > net Income
-4536783
Quarters > 2 > cash Flow > depreciation
4574
Quarters > 2 > cash Flow > change In Working Capital
69095
Quarters > 2 > cash Flow > cash From Operations
-4375610
Quarters > 2 > cash Flow > capital Expenditures
1159
Quarters > 2 > cash Flow > cash From Investing
3239331
Quarters > 2 > cash Flow > cash From Financing
66643290
Quarters > 2 > cash Flow > net Change In Cash
-1133477
Quarters > 2 > ratios > PE
-0.4206674718177793
Quarters > 2 > ratios > PB
2.127825927183197
Quarters > 2 > ratios > ROE
-27.04251218297516
Quarters > 2 > ratios > ROA
-21.505076592687782
Quarters > 2 > ratios > FCF
-4376769
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-43.48330915810599
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
100654
Quarters > 3 > income Statement > cost Of Revenue
51224
Quarters > 3 > income Statement > gross Profit
-51224
Quarters > 3 > income Statement > operating Expenses
5845175
Quarters > 3 > income Statement > operating Income
-5896399
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-5875200
Quarters > 3 > income Statement > net Income
-5875200
Quarters > 3 > income Statement > eps
-0.5447704971614946
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
10784725
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-5823972
Quarters > 3 > income Statement > operating Margin
-5858.0871102986475
Quarters > 3 > income Statement > total Other Income Expense Net
21199
Quarters > 3 > balance Sheet > cash
7511079
Quarters > 3 > balance Sheet > short Term Investments
16501984
Quarters > 3 > balance Sheet > receivables
97000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
25247629
Quarters > 3 > balance Sheet > property Plant Equipment
287425
Quarters > 3 > balance Sheet > total Assets
25571792
Quarters > 3 > balance Sheet > payables
4140361
Quarters > 3 > balance Sheet > short Term Debt
190814
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
4384018
Quarters > 3 > balance Sheet > equity
21187774
Quarters > 3 > cash Flow > net Income
-5875200
Quarters > 3 > cash Flow > depreciation
51224
Quarters > 3 > cash Flow > change In Working Capital
1313315
Quarters > 3 > cash Flow > cash From Operations
-3971787
Quarters > 3 > cash Flow > capital Expenditures
3083
Quarters > 3 > cash Flow > cash From Investing
3447254
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
-591740
Quarters > 3 > ratios > PE
-0.5447704971614946
Quarters > 3 > ratios > PB
1.684813126192492
Quarters > 3 > ratios > ROE
-27.729198923869962
Quarters > 3 > ratios > ROA
-22.975315926236224
Quarters > 3 > ratios > FCF
-3974870
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-39.49043257098575
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
190493
Annuals > 0 > income Statement > gross Profit
-190493
Annuals > 0 > income Statement > operating Expenses
22216437
Annuals > 0 > income Statement > operating Income
-22216437
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-20781213
Annuals > 0 > income Statement > net Income
-20781213
Annuals > 0 > income Statement > eps
-1.93092334468064
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
10762319
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-22199155
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
1435224
Annuals > 0 > balance Sheet > cash
7511079
Annuals > 0 > balance Sheet > short Term Investments
16501984
Annuals > 0 > balance Sheet > receivables
97000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
25247629
Annuals > 0 > balance Sheet > property Plant Equipment
287425
Annuals > 0 > balance Sheet > total Assets
25571792
Annuals > 0 > balance Sheet > payables
4140361
Annuals > 0 > balance Sheet > short Term Debt
190814
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
4384018
Annuals > 0 > balance Sheet > equity
21187774
Annuals > 0 > cash Flow > net Income
-20781213
Annuals > 0 > cash Flow > depreciation
190493
Annuals > 0 > cash Flow > change In Working Capital
2228160
Annuals > 0 > cash Flow > cash From Operations
-17813201
Annuals > 0 > cash Flow > capital Expenditures
12599
Annuals > 0 > cash Flow > cash From Investing
3369368
Annuals > 0 > cash Flow > cash From Financing
66710
Annuals > 0 > cash Flow > net Change In Cash
-14426670
Annuals > 0 > ratios > PE
-1.93092334468064
Annuals > 0 > ratios > PB
1.7829027103083126
Annuals > 0 > ratios > ROE
-98.08115283842464
Annuals > 0 > ratios > ROA
-81.26615842956959
Annuals > 0 > ratios > FCF
-17825800
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
174843
Annuals > 1 > income Statement > gross Profit
-174843
Annuals > 1 > income Statement > operating Expenses
17702727
Annuals > 1 > income Statement > operating Income
-17877570
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-15961534
Annuals > 1 > income Statement > net Income
-15961534
Annuals > 1 > income Statement > eps
-1.472145053224089
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
10842365
Annuals > 1 > income Statement > income Tax Expense
-3
Annuals > 1 > income Statement > EBITDA
-15786689
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
1916036
Annuals > 1 > balance Sheet > cash
21937749
Annuals > 1 > balance Sheet > short Term Investments
19364923
Annuals > 1 > balance Sheet > receivables
860000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
43341325
Annuals > 1 > balance Sheet > property Plant Equipment
280422
Annuals > 1 > balance Sheet > total Assets
43647616
Annuals > 1 > balance Sheet > payables
942211
Annuals > 1 > balance Sheet > short Term Debt
172975
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
2739682
Annuals > 1 > balance Sheet > equity
40907934
Annuals > 1 > cash Flow > net Income
-15961534
Annuals > 1 > cash Flow > depreciation
14615
Annuals > 1 > cash Flow > change In Working Capital
538024
Annuals > 1 > cash Flow > cash From Operations
-14346548
Annuals > 1 > cash Flow > capital Expenditures
18734
Annuals > 1 > cash Flow > cash From Investing
-930210
Annuals > 1 > cash Flow > cash From Financing
-499997
Annuals > 1 > cash Flow > net Change In Cash
-15805217
Annuals > 1 > ratios > PE
-1.472145053224089
Annuals > 1 > ratios > PB
0.9303012259186689
Annuals > 1 > ratios > ROE
-39.018186545426616
Annuals > 1 > ratios > ROA
-36.56908546849385
Annuals > 1 > ratios > FCF
-14365282
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
154681
Annuals > 2 > income Statement > gross Profit
-154681
Annuals > 2 > income Statement > operating Expenses
14432753
Annuals > 2 > income Statement > operating Income
-14432753
Annuals > 2 > income Statement > interest Expense
204355
Annuals > 2 > income Statement > pretax Income
-14259946
Annuals > 2 > income Statement > net Income
-14259946
Annuals > 2 > income Statement > eps
-1.31421060571975
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
10850579
Annuals > 2 > income Statement > income Tax Expense
-172807
Annuals > 2 > income Statement > EBITDA
-14422672
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
172807
Annuals > 2 > balance Sheet > cash
37201786
Annuals > 2 > balance Sheet > short Term Investments
17994299
Annuals > 2 > balance Sheet > receivables
592000
Annuals > 2 > balance Sheet > inventories
-592000
Annuals > 2 > balance Sheet > total Current Assets
58722737
Annuals > 2 > balance Sheet > property Plant Equipment
95695
Annuals > 2 > balance Sheet > total Assets
58836321
Annuals > 2 > balance Sheet > payables
932407
Annuals > 2 > balance Sheet > short Term Debt
52890
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2798297
Annuals > 2 > balance Sheet > equity
56038024
Annuals > 2 > cash Flow > net Income
-14259946
Annuals > 2 > cash Flow > depreciation
10081
Annuals > 2 > cash Flow > change In Working Capital
-611863
Annuals > 2 > cash Flow > cash From Operations
-12767492
Annuals > 2 > cash Flow > capital Expenditures
27844
Annuals > 2 > cash Flow > cash From Investing
179268
Annuals > 2 > cash Flow > cash From Financing
-2182498
Annuals > 2 > cash Flow > net Change In Cash
-14781329
Annuals > 2 > ratios > PE
-1.31421060571975
Annuals > 2 > ratios > PB
0.6796373171545091
Annuals > 2 > ratios > ROE
-25.446910833258503
Annuals > 2 > ratios > ROA
-24.236637773459695
Annuals > 2 > ratios > FCF
-12795336
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
97421
Annuals > 3 > income Statement > gross Profit
-97421
Annuals > 3 > income Statement > operating Expenses
12591508
Annuals > 3 > income Statement > operating Income
-12591508
Annuals > 3 > income Statement > interest Expense
221718
Annuals > 3 > income Statement > pretax Income
-12363029
Annuals > 3 > income Statement > net Income
-12363029
Annuals > 3 > income Statement > eps
-1.1337103861401365
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
10904927
Annuals > 3 > income Statement > income Tax Expense
-67929
Annuals > 3 > income Statement > EBITDA
-12584747
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
228479
Annuals > 3 > balance Sheet > cash
51524295
Annuals > 3 > balance Sheet > short Term Investments
19201152
Annuals > 3 > balance Sheet > receivables
181000
Annuals > 3 > balance Sheet > inventories
-181000
Annuals > 3 > balance Sheet > total Current Assets
72716400
Annuals > 3 > balance Sheet > property Plant Equipment
216188
Annuals > 3 > balance Sheet > total Assets
73950477
Annuals > 3 > balance Sheet > payables
2174109
Annuals > 3 > balance Sheet > short Term Debt
152058
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2379057
Annuals > 3 > balance Sheet > equity
71571420
Annuals > 3 > cash Flow > net Income
-12363029
Annuals > 3 > cash Flow > depreciation
6761
Annuals > 3 > cash Flow > change In Working Capital
599957
Annuals > 3 > cash Flow > cash From Operations
-10591543
Annuals > 3 > cash Flow > capital Expenditures
15499
Annuals > 3 > cash Flow > cash From Investing
-19530586
Annuals > 3 > cash Flow > cash From Financing
63416122
Annuals > 3 > cash Flow > net Change In Cash
33295063
Annuals > 3 > ratios > PE
-1.1337103861401365
Annuals > 3 > ratios > PB
0.534798579796237
Annuals > 3 > ratios > ROE
-17.273695282278876
Annuals > 3 > ratios > ROA
-16.71798411793882
Annuals > 3 > ratios > FCF
-10607042
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.3856061531230336
Valuation > metrics > PB
3.7403918612163887
Valuation > final Score
42.596081387836115
Valuation > verdict
24.7% Overvalued
Profitability > metrics > ROE
-43.57456546152131
Profitability > metrics > ROA
-31.033514956721287
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.4214080805370864
Risk > metrics > Interest Coverage
-1060.409556313993
Risk > final Score
-4182
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.3319550234506576
Liquidity > metrics > Quick Ratio
3.3319550234506576
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
1
Prev Risks > 1
-22
Prev Risks > 2
-400
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T22:57:32.799Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-05
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.39
Earnings History > 0 > eps Estimate
-0.44
Earnings History > 0 > eps Difference
0.05
Earnings History > 0 > surprise Percent
11.3636
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-13
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.4
Earnings History > 1 > eps Estimate
-0.53
Earnings History > 1 > eps Difference
0.13
Earnings History > 1 > surprise Percent
24.5283
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.42
Earnings History > 2 > eps Estimate
-0.43
Earnings History > 2 > eps Difference
0.01
Earnings History > 2 > surprise Percent
2.3256
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-17
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.54
Earnings History > 3 > eps Estimate
-0.51
Earnings History > 3 > eps Difference
-0.03
Earnings History > 3 > surprise Percent
-5.8824
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.42
Earnings History > 4 > eps Estimate
-0.56
Earnings History > 4 > eps Difference
0.14
Earnings History > 4 > surprise Percent
25
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.46
Earnings History > 5 > eps Estimate
-0.55
Earnings History > 5 > eps Difference
0.09
Earnings History > 5 > surprise Percent
16.3636
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.51
Earnings History > 6 > eps Estimate
-0.43
Earnings History > 6 > eps Difference
-0.08
Earnings History > 6 > surprise Percent
-18.6047
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-18
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.39
Earnings History > 7 > eps Estimate
-0.4
Earnings History > 7 > eps Difference
0.01
Earnings History > 7 > surprise Percent
2.5
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-08
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.29
Earnings History > 8 > eps Estimate
-0.45
Earnings History > 8 > eps Difference
0.16
Earnings History > 8 > surprise Percent
35.5556
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-09
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.44
Earnings History > 9 > eps Estimate
-0.43
Earnings History > 9 > eps Difference
-0.01
Earnings History > 9 > surprise Percent
-2.3256
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-09
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.36
Earnings History > 10 > eps Estimate
-0.48
Earnings History > 10 > eps Difference
0.12
Earnings History > 10 > surprise Percent
25
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-20
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.31
Earnings History > 11 > eps Estimate
-0.47
Earnings History > 11 > eps Difference
0.16
Earnings History > 11 > surprise Percent
34.0426
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-07
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.21
Earnings History > 12 > eps Estimate
-0.48
Earnings History > 12 > eps Difference
0.27
Earnings History > 12 > surprise Percent
56.25
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-08
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.41
Earnings History > 13 > eps Estimate
-0.52
Earnings History > 13 > eps Difference
0.11
Earnings History > 13 > surprise Percent
21.1538
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-03
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.38
Earnings History > 14 > eps Estimate
-0.29
Earnings History > 14 > eps Difference
-0.09
Earnings History > 14 > surprise Percent
-31.0345
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-10
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.32
Earnings History > 15 > eps Estimate
-0.4
Earnings History > 15 > eps Difference
0.08
Earnings History > 15 > surprise Percent
20
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-01
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.36
Earnings History > 16 > eps Estimate
-0.27
Earnings History > 16 > eps Difference
-0.09
Earnings History > 16 > surprise Percent
-33.3333
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-07-29
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.21
Earnings History > 17 > eps Estimate
-0.26
Earnings History > 17 > eps Difference
0.05
Earnings History > 17 > surprise Percent
19.2308
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-03
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.24
Earnings History > 18 > eps Estimate
-0.27
Earnings History > 18 > eps Difference
0.03
Earnings History > 18 > surprise Percent
11.1111
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-10
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.47
Earnings History > 19 > eps Estimate
-0.45
Earnings History > 19 > eps Difference
-0.02
Earnings History > 19 > surprise Percent
-4.4444
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-10-29
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.27
Earnings History > 20 > eps Estimate
-0.33
Earnings History > 20 > eps Difference
0.06
Earnings History > 20 > surprise Percent
18.1818
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-07-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.31
Earnings History > 21 > eps Estimate
-0.31
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
0
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-12
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.4
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.4
Earnings History > 22 > surprise Percent
-
Lantern Pharma Inc. focuses on the discovery and development of oncology drug. Its product pipeline comprises LP-300, which is in phase 2 clinical trial in combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma; LP-184, which is in phase 1 clinical trial for the treatment of solid tumor, such as pancreatic, breast, bladder, and lung cancers, as well as glioblastoma and other central nervous system (CNS) cancers; and LP-284, which is in phase 1 clinical trial for the treatment of non-Hodgkin's lymphomas, including mantle cell lymphoma and double hit lymphoma. The company also develops STAR-001, which is in preclinical development for the treatment of glioblastoma, brain metastases, atypical teratoid rhabdoid tumors, and several rare pediatric CNS cancers. In addition, it provides ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. The company has a strategic AI-driven collaboration with Oregon Therapeutics to optimize the development of its first-in-class protein disulfide isomerase inhibitor drug candidate XCE853 in novel and targeted cancer indications; a collaboration agreement with TTC Oncology, which focuses on the drug development of TTC-352 to treat patients with metastatic ER+ breast cancer; and a collaboration agreement with Actuate Therapeutics, Inc. that focuses on the development of compounds for use in the treatment of cancer and inflammatory diseases. The company was incorporated in 2013 and is headquartered in Dallas, Texas.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ALantern Pharma (NASDAQ:LTRN) Shares Down 6.4% – Should You Sell? Defense World
Read more →Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV Pensacola News Journal
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$22
Analyst Picks
Strong Buy
2
Buy
0
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 25.65% of the total shares of Lantern Pharma Inc
1.
BIOS CAPITAL MANAGEMENT, LP(9.9631%)
since
2025/06/30
2.
Vanguard Group Inc(3.368%)
since
2025/06/30
3.
Vanguard Total Stock Mkt Idx Inv(2.3208%)
since
2025/07/31
4.
CM Management, LLC(1.852%)
since
2025/06/30
5.
Geode Capital Management, LLC(0.8509%)
since
2025/06/30
6.
Renaissance Technologies Corp(0.8389%)
since
2025/06/30
7.
Vanguard Institutional Extnd Mkt Idx Tr(0.6324%)
since
2025/07/31
8.
Goss Wealth Management LLC(0.5232%)
since
2025/06/30
9.
Voss Capital LLC(0.463%)
since
2025/06/30
10.
Fidelity Extended Market Index(0.398%)
since
2025/07/31
11.
BlackRock Inc(0.3915%)
since
2025/06/30
12.
Dimensional Fund Advisors, Inc.(0.3791%)
since
2025/06/30
13.
Westside Investment Management, Inc.(0.3324%)
since
2025/06/30
14.
Horizon Kinetics Medical ETF(0.2666%)
since
2025/08/29
15.
Horizon Asset Management Inc/ny(0.2554%)
since
2025/06/30
16.
Bank of New York Mellon Corp(0.2452%)
since
2025/06/30
17.
Davenport & Company LLC(0.239%)
since
2025/06/30
18.
UBS Group AG(0.2283%)
since
2025/06/30
19.
State Street Corp(0.219%)
since
2025/06/30
20.
DFA US Targeted Value I(0.2004%)
since
2025/07/31
21.
Commonwealth Equity Services Inc(0.1682%)
since
2025/06/30
22.
iShares Micro-Cap ETF(0.1653%)
since
2025/08/31
23.
Northern Trust Corp(0.1444%)
since
2025/06/30
24.
Fidelity Total Market Index(0.1423%)
since
2025/07/31
25.
Extended Equity Market Fund K(0.1398%)
since
2025/06/30
26.
XTX Topco Ltd(0.1169%)
since
2025/06/30
27.
Fidelity Series Total Market Index(0.1107%)
since
2025/07/31
28.
Spartan Extended Market Index Pool F(0.097%)
since
2025/07/31
29.
Northern Trust Extended Eq Market Idx(0.0799%)
since
2025/06/30
30.
NT Ext Equity Mkt Idx Fd - L(0.0799%)
since
2025/06/30
31.
Fidelity Nasdaq Composite Index(0.0633%)
since
2025/07/31
32.
NT Ext Equity Mkt Idx Fd - NL(0.06%)
since
2025/06/30
33.
Vanguard Instl Ttl Stck Mkt Idx Tr(0.0554%)
since
2024/12/31
34.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0466%)
since
2025/06/30
35.
Wells Fargo & Co(0.0462%)
since
2025/06/30
36.
Spartan Total Market Index Pool G(0.0422%)
since
2025/07/31
37.
Dimensional US Targeted Value ETF(0.0343%)
since
2025/08/29
38.
DFA US Vector Equity Class F(0.032%)
since
2025/06/30
39.
Group One Trading, LP(0.0275%)
since
2025/06/30
40.
DFA US Core Equity 2 I(0.026%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.39
EPS Estimate
-0.44
EPS Difference
0.05
Surprise Percent
11.3636%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.